High mortality of COVID‐19 in children with cancer in a single center in Algiers, Algeria

Recent publications suggest that the pediatric oncology population may not have higher mortality resulting from SARS‐CoV‐2 infection in high‐income countries such as Spain, China, USA, Italy, and France.5-9 We present a case series of pediatric oncology patients infected with COVID‐19 in the Pediatr...

Full description

Saved in:
Bibliographic Details
Published inPediatric Blood & Cancer Vol. 68; no. 6; pp. e28898 - n/a
Main Authors Arous, Radjaa, Djillali, Imene Sarah, Rouis, Nassiba Ould, Boudiaf, Houda, Amhis, Wahiba, Ziane, Hanifa, Ladj, Mohamed Samir, Boukari, Rachida
Format Journal Article Web Resource
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.06.2021
Wiley Subscription Services, Inc
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recent publications suggest that the pediatric oncology population may not have higher mortality resulting from SARS‐CoV‐2 infection in high‐income countries such as Spain, China, USA, Italy, and France.5-9 We present a case series of pediatric oncology patients infected with COVID‐19 in the Pediatric Oncology Department of the University Hospital Mustapha Bachain Algiers during the period from June 1 to August 31, 2020. Patient demographics and clinical characteristics Age (years) ≤2 years 1 ≥ 2 years 6 Sex Male 3 Female 4 Underlying cancer Leukemia 5 Lymphoma 1 Neuroblastoma 1 Symptoms at onset Fever Cough 4 Diarrhea 2 Seizure 1 Skin lesions 1 Hospitalization status Not admitted 3 Admitted 4 Oxygen requirement None 4 Low‐flow oxygen 1 High‐flow oxygen 2 Deaths 2 The most frequent symptoms were fever and cough (four cases), followed by diarrhea (two cases), skin lesions (one case), and seizures (one case); three patients were asymptomatic. Two patients experienced complications of the viral disease and died: the first patient was treated for a relapse of acute lymphoid leukemia (ALL) after allogenic hematopoietic stem cell transplantation and developed severe respiratory distress and seizure; the second patient, with refractory ALL, had previously been given intensive chemotherapy and developed rapid respiratory deterioration.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.28898